Despite the high frequency of IgG antibodies directed to Stx2 identified in the present study, we observed that the percentage of individuals showing antibodies against Stx2 was higher among HUS patients than controls (p < 0.05). This evidence concerns the gene STX2 and hemolytic-uremic syndrome.